Cargando…

Prenatal substance use policies and newborn health

We study the effect of punitive and priority treatment policies relating to illicit substance use during pregnancy on the rate of neonatal drug withdrawal syndrome, low birth weight, low gestational age, and prenatal care use. Punitive policies criminalize prenatal substance use, or define prenatal...

Descripción completa

Detalles Bibliográficos
Autores principales: Meinhofer, Angélica, Witman, Allison, Maclean, Johanna Catherine, Bao, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177792/
https://www.ncbi.nlm.nih.gov/pubmed/35445500
http://dx.doi.org/10.1002/hec.4518
_version_ 1784722931278938112
author Meinhofer, Angélica
Witman, Allison
Maclean, Johanna Catherine
Bao, Yuhua
author_facet Meinhofer, Angélica
Witman, Allison
Maclean, Johanna Catherine
Bao, Yuhua
author_sort Meinhofer, Angélica
collection PubMed
description We study the effect of punitive and priority treatment policies relating to illicit substance use during pregnancy on the rate of neonatal drug withdrawal syndrome, low birth weight, low gestational age, and prenatal care use. Punitive policies criminalize prenatal substance use, or define prenatal substance exposure as child maltreatment in child welfare statutes or as grounds for termination of parental rights. Priority treatment policies are supportive and grant pregnant women priority access to substance use disorder treatment programs. Our empirical strategy relies on administrative data from 2008 to 2018 and a difference‐in‐differences framework that exploits the staggered implementation of these policies. We find that neonatal drug withdrawal syndrome increases by 10%–18% following the implementation of a punitive policy. This growth is accompanied by modest reductions in prenatal care, which may reflect deterrence from healthcare utilization. In contrast, priority treatment policies are associated with small reductions in low gestational age (2%) and low birth weight (2%), along with increases in prenatal care use. Taken together, our findings suggest that punitive approaches may be associated with unintended adverse pregnancy outcomes, and that supportive approaches may be more effective for improving perinatal health.
format Online
Article
Text
id pubmed-9177792
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91777922022-10-14 Prenatal substance use policies and newborn health Meinhofer, Angélica Witman, Allison Maclean, Johanna Catherine Bao, Yuhua Health Econ Research Articles We study the effect of punitive and priority treatment policies relating to illicit substance use during pregnancy on the rate of neonatal drug withdrawal syndrome, low birth weight, low gestational age, and prenatal care use. Punitive policies criminalize prenatal substance use, or define prenatal substance exposure as child maltreatment in child welfare statutes or as grounds for termination of parental rights. Priority treatment policies are supportive and grant pregnant women priority access to substance use disorder treatment programs. Our empirical strategy relies on administrative data from 2008 to 2018 and a difference‐in‐differences framework that exploits the staggered implementation of these policies. We find that neonatal drug withdrawal syndrome increases by 10%–18% following the implementation of a punitive policy. This growth is accompanied by modest reductions in prenatal care, which may reflect deterrence from healthcare utilization. In contrast, priority treatment policies are associated with small reductions in low gestational age (2%) and low birth weight (2%), along with increases in prenatal care use. Taken together, our findings suggest that punitive approaches may be associated with unintended adverse pregnancy outcomes, and that supportive approaches may be more effective for improving perinatal health. John Wiley and Sons Inc. 2022-04-20 2022-07 /pmc/articles/PMC9177792/ /pubmed/35445500 http://dx.doi.org/10.1002/hec.4518 Text en © 2022 The Authors. Health Economics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Meinhofer, Angélica
Witman, Allison
Maclean, Johanna Catherine
Bao, Yuhua
Prenatal substance use policies and newborn health
title Prenatal substance use policies and newborn health
title_full Prenatal substance use policies and newborn health
title_fullStr Prenatal substance use policies and newborn health
title_full_unstemmed Prenatal substance use policies and newborn health
title_short Prenatal substance use policies and newborn health
title_sort prenatal substance use policies and newborn health
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177792/
https://www.ncbi.nlm.nih.gov/pubmed/35445500
http://dx.doi.org/10.1002/hec.4518
work_keys_str_mv AT meinhoferangelica prenatalsubstanceusepoliciesandnewbornhealth
AT witmanallison prenatalsubstanceusepoliciesandnewbornhealth
AT macleanjohannacatherine prenatalsubstanceusepoliciesandnewbornhealth
AT baoyuhua prenatalsubstanceusepoliciesandnewbornhealth